nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenobarbital—CYP4A11—Dexamethasone—ankylosing spondylitis	0.144	0.154	CbGbCtD
Phenobarbital—ABCC2—Sulfasalazine—ankylosing spondylitis	0.0631	0.0675	CbGbCtD
Phenobarbital—CYP1B1—Dexamethasone—ankylosing spondylitis	0.0599	0.0641	CbGbCtD
Phenobarbital—ABCB11—Dexamethasone—ankylosing spondylitis	0.0599	0.0641	CbGbCtD
Phenobarbital—ABCC3—Methotrexate—ankylosing spondylitis	0.0557	0.0596	CbGbCtD
Phenobarbital—CYP2A6—Prednisolone—ankylosing spondylitis	0.0521	0.0558	CbGbCtD
Phenobarbital—ABCC1—Methotrexate—ankylosing spondylitis	0.0342	0.0366	CbGbCtD
Phenobarbital—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0316	0.0338	CbGbCtD
Phenobarbital—ABCC2—Dexamethasone—ankylosing spondylitis	0.0315	0.0337	CbGbCtD
Phenobarbital—CYP2A6—Dexamethasone—ankylosing spondylitis	0.0307	0.0329	CbGbCtD
Phenobarbital—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0271	0.029	CbGbCtD
Phenobarbital—CYP1A1—Dexamethasone—ankylosing spondylitis	0.0263	0.0281	CbGbCtD
Phenobarbital—ABCC2—Methotrexate—ankylosing spondylitis	0.0253	0.0271	CbGbCtD
Phenobarbital—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.021	0.0225	CbGbCtD
Phenobarbital—CYP3A7—Dexamethasone—ankylosing spondylitis	0.021	0.0225	CbGbCtD
Phenobarbital—CYP2C19—Prednisone—ankylosing spondylitis	0.0204	0.0218	CbGbCtD
Phenobarbital—CYP2E1—Dexamethasone—ankylosing spondylitis	0.0203	0.0217	CbGbCtD
Phenobarbital—CYP2B6—Dexamethasone—ankylosing spondylitis	0.02	0.0214	CbGbCtD
Phenobarbital—ABCB1—Betamethasone—ankylosing spondylitis	0.0176	0.0189	CbGbCtD
Phenobarbital—ABCB1—Prednisolone—ankylosing spondylitis	0.0174	0.0186	CbGbCtD
Phenobarbital—ABCB1—Prednisone—ankylosing spondylitis	0.0164	0.0176	CbGbCtD
Phenobarbital—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0163	0.0174	CbGbCtD
Phenobarbital—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0158	0.0169	CbGbCtD
Phenobarbital—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0152	0.0162	CbGbCtD
Phenobarbital—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0127	0.0136	CbGbCtD
Phenobarbital—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0123	0.0132	CbGbCtD
Phenobarbital—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0106	0.0113	CbGbCtD
Phenobarbital—CYP3A4—Betamethasone—ankylosing spondylitis	0.0106	0.0113	CbGbCtD
Phenobarbital—CYP3A4—Prednisolone—ankylosing spondylitis	0.0104	0.0112	CbGbCtD
Phenobarbital—ABCB1—Dexamethasone—ankylosing spondylitis	0.0103	0.011	CbGbCtD
Phenobarbital—CYP3A4—Prednisone—ankylosing spondylitis	0.00985	0.0105	CbGbCtD
Phenobarbital—ABCB1—Methotrexate—ankylosing spondylitis	0.00825	0.00883	CbGbCtD
Phenobarbital—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00615	0.00658	CbGbCtD
Phenobarbital—Anaemia megaloblastic—Methotrexate—ankylosing spondylitis	0.00203	0.0309	CcSEcCtD
Phenobarbital—Blister—Prednisolone—ankylosing spondylitis	0.00109	0.0166	CcSEcCtD
Phenobarbital—Suicidal ideation—Methylprednisolone—ankylosing spondylitis	0.00103	0.0157	CcSEcCtD
Phenobarbital—Blister—Triamcinolone—ankylosing spondylitis	0.00101	0.0153	CcSEcCtD
Phenobarbital—Suicidal ideation—Dexamethasone—ankylosing spondylitis	0.000938	0.0143	CcSEcCtD
Phenobarbital—Suicidal ideation—Betamethasone—ankylosing spondylitis	0.000938	0.0143	CcSEcCtD
Phenobarbital—Necrosis—Methylprednisolone—ankylosing spondylitis	0.000922	0.014	CcSEcCtD
Phenobarbital—Blister—Dexamethasone—ankylosing spondylitis	0.000913	0.0139	CcSEcCtD
Phenobarbital—Blister—Betamethasone—ankylosing spondylitis	0.000913	0.0139	CcSEcCtD
Phenobarbital—Necrosis—Dexamethasone—ankylosing spondylitis	0.000838	0.0127	CcSEcCtD
Phenobarbital—Necrosis—Betamethasone—ankylosing spondylitis	0.000838	0.0127	CcSEcCtD
Phenobarbital—Suicidal ideation—Prednisone—ankylosing spondylitis	0.000817	0.0124	CcSEcCtD
Phenobarbital—Extravasation—Dexamethasone—ankylosing spondylitis	0.000754	0.0115	CcSEcCtD
Phenobarbital—Extravasation—Betamethasone—ankylosing spondylitis	0.000754	0.0115	CcSEcCtD
Phenobarbital—Hypoxia—Methotrexate—ankylosing spondylitis	0.000754	0.0115	CcSEcCtD
Phenobarbital—Necrosis—Prednisone—ankylosing spondylitis	0.00073	0.0111	CcSEcCtD
Phenobarbital—Delirium—Prednisone—ankylosing spondylitis	0.000666	0.0101	CcSEcCtD
Phenobarbital—Necrosis—Methotrexate—ankylosing spondylitis	0.00061	0.00927	CcSEcCtD
Phenobarbital—Dermatitis bullous—Prednisolone—ankylosing spondylitis	0.000599	0.0091	CcSEcCtD
Phenobarbital—Apnoea—Methotrexate—ankylosing spondylitis	0.000565	0.00858	CcSEcCtD
Phenobarbital—Affect lability—Prednisolone—ankylosing spondylitis	0.000563	0.00856	CcSEcCtD
Phenobarbital—Dermatitis bullous—Triamcinolone—ankylosing spondylitis	0.000551	0.00837	CcSEcCtD
Phenobarbital—Extravasation—Methotrexate—ankylosing spondylitis	0.000549	0.00834	CcSEcCtD
Phenobarbital—Mood swings—Prednisolone—ankylosing spondylitis	0.000542	0.00824	CcSEcCtD
Phenobarbital—Affect lability—Triamcinolone—ankylosing spondylitis	0.000518	0.00787	CcSEcCtD
Phenobarbital—Affect lability—Methylprednisolone—ankylosing spondylitis	0.000517	0.00785	CcSEcCtD
Phenobarbital—Irritability—Methylprednisolone—ankylosing spondylitis	0.000501	0.00762	CcSEcCtD
Phenobarbital—Hyperkinesia—Prednisone—ankylosing spondylitis	0.0005	0.00759	CcSEcCtD
Phenobarbital—Dermatitis bullous—Betamethasone—ankylosing spondylitis	0.0005	0.00759	CcSEcCtD
Phenobarbital—Dermatitis bullous—Dexamethasone—ankylosing spondylitis	0.0005	0.00759	CcSEcCtD
Phenobarbital—Mood swings—Triamcinolone—ankylosing spondylitis	0.000499	0.00757	CcSEcCtD
Phenobarbital—Mood swings—Methylprednisolone—ankylosing spondylitis	0.000497	0.00756	CcSEcCtD
Phenobarbital—Respiratory failure—Methotrexate—ankylosing spondylitis	0.000488	0.00741	CcSEcCtD
Phenobarbital—Lethargy—Betamethasone—ankylosing spondylitis	0.000487	0.0074	CcSEcCtD
Phenobarbital—Lethargy—Dexamethasone—ankylosing spondylitis	0.000487	0.0074	CcSEcCtD
Phenobarbital—Affect lability—Dexamethasone—ankylosing spondylitis	0.00047	0.00714	CcSEcCtD
Phenobarbital—Affect lability—Betamethasone—ankylosing spondylitis	0.00047	0.00714	CcSEcCtD
Phenobarbital—Depressed level of consciousness—Methotrexate—ankylosing spondylitis	0.000462	0.00702	CcSEcCtD
Phenobarbital—Irritability—Dexamethasone—ankylosing spondylitis	0.000456	0.00692	CcSEcCtD
Phenobarbital—Irritability—Betamethasone—ankylosing spondylitis	0.000456	0.00692	CcSEcCtD
Phenobarbital—Asthma—Triamcinolone—ankylosing spondylitis	0.000455	0.00691	CcSEcCtD
Phenobarbital—Mood swings—Dexamethasone—ankylosing spondylitis	0.000452	0.00687	CcSEcCtD
Phenobarbital—Mood swings—Betamethasone—ankylosing spondylitis	0.000452	0.00687	CcSEcCtD
Phenobarbital—Coma—Methotrexate—ankylosing spondylitis	0.000437	0.00665	CcSEcCtD
Phenobarbital—Lethargy—Prednisone—ankylosing spondylitis	0.000424	0.00645	CcSEcCtD
Phenobarbital—Affect lability—Prednisone—ankylosing spondylitis	0.000409	0.00622	CcSEcCtD
Phenobarbital—Bradycardia—Prednisolone—ankylosing spondylitis	0.000403	0.00612	CcSEcCtD
Phenobarbital—Irritability—Prednisone—ankylosing spondylitis	0.000397	0.00603	CcSEcCtD
Phenobarbital—Mood swings—Prednisone—ankylosing spondylitis	0.000394	0.00599	CcSEcCtD
Phenobarbital—Bradycardia—Triamcinolone—ankylosing spondylitis	0.000371	0.00563	CcSEcCtD
Phenobarbital—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00037	0.00562	CcSEcCtD
Phenobarbital—Dermatitis exfoliative—Methotrexate—ankylosing spondylitis	0.000368	0.0056	CcSEcCtD
Phenobarbital—Hallucination—Methylprednisolone—ankylosing spondylitis	0.000361	0.00549	CcSEcCtD
Phenobarbital—Lethargy—Methotrexate—ankylosing spondylitis	0.000355	0.00539	CcSEcCtD
Phenobarbital—Erythema—Prednisolone—ankylosing spondylitis	0.000345	0.00524	CcSEcCtD
Phenobarbital—Bradycardia—Betamethasone—ankylosing spondylitis	0.000336	0.00511	CcSEcCtD
Phenobarbital—Bradycardia—Dexamethasone—ankylosing spondylitis	0.000336	0.00511	CcSEcCtD
Phenobarbital—Irritability—Methotrexate—ankylosing spondylitis	0.000332	0.00504	CcSEcCtD
Phenobarbital—Mood swings—Methotrexate—ankylosing spondylitis	0.000329	0.005	CcSEcCtD
Phenobarbital—Hallucination—Dexamethasone—ankylosing spondylitis	0.000329	0.00499	CcSEcCtD
Phenobarbital—Hallucination—Betamethasone—ankylosing spondylitis	0.000329	0.00499	CcSEcCtD
Phenobarbital—Ataxia—Methotrexate—ankylosing spondylitis	0.000327	0.00497	CcSEcCtD
Phenobarbital—Erythema—Triamcinolone—ankylosing spondylitis	0.000317	0.00482	CcSEcCtD
Phenobarbital—Erythema—Methylprednisolone—ankylosing spondylitis	0.000316	0.0048	CcSEcCtD
Phenobarbital—Angioedema—Prednisolone—ankylosing spondylitis	0.000315	0.00478	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.000313	0.00476	CcSEcCtD
Phenobarbital—Vertigo—Prednisolone—ankylosing spondylitis	0.00031	0.0047	CcSEcCtD
Phenobarbital—Syncope—Prednisolone—ankylosing spondylitis	0.000309	0.0047	CcSEcCtD
Phenobarbital—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000303	0.0046	CcSEcCtD
Phenobarbital—Asthma—Methotrexate—ankylosing spondylitis	0.0003	0.00456	CcSEcCtD
Phenobarbital—Bradycardia—Prednisone—ankylosing spondylitis	0.000293	0.00445	CcSEcCtD
Phenobarbital—Angioedema—Triamcinolone—ankylosing spondylitis	0.00029	0.0044	CcSEcCtD
Phenobarbital—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000289	0.00439	CcSEcCtD
Phenobarbital—Erythema—Dexamethasone—ankylosing spondylitis	0.000288	0.00437	CcSEcCtD
Phenobarbital—Erythema—Betamethasone—ankylosing spondylitis	0.000288	0.00437	CcSEcCtD
Phenobarbital—Hallucination—Prednisone—ankylosing spondylitis	0.000286	0.00435	CcSEcCtD
Phenobarbital—Vertigo—Triamcinolone—ankylosing spondylitis	0.000285	0.00433	CcSEcCtD
Phenobarbital—Syncope—Triamcinolone—ankylosing spondylitis	0.000284	0.00432	CcSEcCtD
Phenobarbital—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000284	0.00432	CcSEcCtD
Phenobarbital—Syncope—Methylprednisolone—ankylosing spondylitis	0.000284	0.00431	CcSEcCtD
Phenobarbital—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000279	0.00423	CcSEcCtD
Phenobarbital—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000278	0.00422	CcSEcCtD
Phenobarbital—Shock—Prednisolone—ankylosing spondylitis	0.000277	0.0042	CcSEcCtD
Phenobarbital—Myalgia—Triamcinolone—ankylosing spondylitis	0.00027	0.0041	CcSEcCtD
Phenobarbital—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000269	0.00409	CcSEcCtD
Phenobarbital—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000269	0.00409	CcSEcCtD
Phenobarbital—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000268	0.00408	CcSEcCtD
Phenobarbital—Drowsiness—Methotrexate—ankylosing spondylitis	0.000268	0.00407	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000266	0.00403	CcSEcCtD
Phenobarbital—Renal failure—Methotrexate—ankylosing spondylitis	0.000263	0.004	CcSEcCtD
Phenobarbital—Angioedema—Dexamethasone—ankylosing spondylitis	0.000263	0.00399	CcSEcCtD
Phenobarbital—Angioedema—Betamethasone—ankylosing spondylitis	0.000263	0.00399	CcSEcCtD
Phenobarbital—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00026	0.00395	CcSEcCtD
Phenobarbital—Vertigo—Betamethasone—ankylosing spondylitis	0.000258	0.00393	CcSEcCtD
Phenobarbital—Vertigo—Dexamethasone—ankylosing spondylitis	0.000258	0.00393	CcSEcCtD
Phenobarbital—Syncope—Dexamethasone—ankylosing spondylitis	0.000258	0.00392	CcSEcCtD
Phenobarbital—Syncope—Betamethasone—ankylosing spondylitis	0.000258	0.00392	CcSEcCtD
Phenobarbital—Shock—Triamcinolone—ankylosing spondylitis	0.000254	0.00387	CcSEcCtD
Phenobarbital—Shock—Methylprednisolone—ankylosing spondylitis	0.000254	0.00386	CcSEcCtD
Phenobarbital—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000253	0.00384	CcSEcCtD
Phenobarbital—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000253	0.00384	CcSEcCtD
Phenobarbital—Erythema—Prednisone—ankylosing spondylitis	0.00025	0.00381	CcSEcCtD
Phenobarbital—Myalgia—Dexamethasone—ankylosing spondylitis	0.000245	0.00372	CcSEcCtD
Phenobarbital—Myalgia—Betamethasone—ankylosing spondylitis	0.000245	0.00372	CcSEcCtD
Phenobarbital—Anxiety—Dexamethasone—ankylosing spondylitis	0.000244	0.00371	CcSEcCtD
Phenobarbital—Anxiety—Betamethasone—ankylosing spondylitis	0.000244	0.00371	CcSEcCtD
Phenobarbital—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000241	0.00366	CcSEcCtD
Phenobarbital—Pain—Prednisolone—ankylosing spondylitis	0.000241	0.00365	CcSEcCtD
Phenobarbital—Hepatitis—Methotrexate—ankylosing spondylitis	0.00024	0.00365	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000236	0.00358	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000235	0.00357	CcSEcCtD
Phenobarbital—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000232	0.00352	CcSEcCtD
Phenobarbital—Shock—Dexamethasone—ankylosing spondylitis	0.000231	0.00351	CcSEcCtD
Phenobarbital—Shock—Betamethasone—ankylosing spondylitis	0.000231	0.00351	CcSEcCtD
Phenobarbital—Agitation—Prednisone—ankylosing spondylitis	0.00023	0.0035	CcSEcCtD
Phenobarbital—Angioedema—Prednisone—ankylosing spondylitis	0.000229	0.00348	CcSEcCtD
Phenobarbital—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000227	0.00345	CcSEcCtD
Phenobarbital—Vertigo—Prednisone—ankylosing spondylitis	0.000225	0.00342	CcSEcCtD
Phenobarbital—Syncope—Prednisone—ankylosing spondylitis	0.000225	0.00341	CcSEcCtD
Phenobarbital—Urticaria—Prednisolone—ankylosing spondylitis	0.000223	0.0034	CcSEcCtD
Phenobarbital—Pain—Triamcinolone—ankylosing spondylitis	0.000221	0.00336	CcSEcCtD
Phenobarbital—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00022	0.00334	CcSEcCtD
Phenobarbital—Hypotension—Dexamethasone—ankylosing spondylitis	0.000219	0.00333	CcSEcCtD
Phenobarbital—Hypotension—Betamethasone—ankylosing spondylitis	0.000219	0.00333	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000214	0.00325	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000214	0.00325	CcSEcCtD
Phenobarbital—Myalgia—Prednisone—ankylosing spondylitis	0.000213	0.00324	CcSEcCtD
Phenobarbital—Arthralgia—Prednisone—ankylosing spondylitis	0.000213	0.00324	CcSEcCtD
Phenobarbital—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000213	0.00324	CcSEcCtD
Phenobarbital—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000213	0.00323	CcSEcCtD
Phenobarbital—Anxiety—Prednisone—ankylosing spondylitis	0.000212	0.00323	CcSEcCtD
Phenobarbital—Erythema—Methotrexate—ankylosing spondylitis	0.000209	0.00318	CcSEcCtD
Phenobarbital—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000207	0.00315	CcSEcCtD
Phenobarbital—Urticaria—Triamcinolone—ankylosing spondylitis	0.000205	0.00312	CcSEcCtD
Phenobarbital—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000205	0.00312	CcSEcCtD
Phenobarbital—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000204	0.00311	CcSEcCtD
Phenobarbital—Shock—Prednisone—ankylosing spondylitis	0.000201	0.00306	CcSEcCtD
Phenobarbital—Pain—Dexamethasone—ankylosing spondylitis	0.000201	0.00305	CcSEcCtD
Phenobarbital—Pain—Betamethasone—ankylosing spondylitis	0.000201	0.00305	CcSEcCtD
Phenobarbital—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000193	0.00294	CcSEcCtD
Phenobarbital—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000193	0.00294	CcSEcCtD
Phenobarbital—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000191	0.0029	CcSEcCtD
Phenobarbital—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00019	0.00289	CcSEcCtD
Phenobarbital—Vertigo—Methotrexate—ankylosing spondylitis	0.000188	0.00286	CcSEcCtD
Phenobarbital—Urticaria—Betamethasone—ankylosing spondylitis	0.000186	0.00283	CcSEcCtD
Phenobarbital—Urticaria—Dexamethasone—ankylosing spondylitis	0.000186	0.00283	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000186	0.00283	CcSEcCtD
Phenobarbital—Dizziness—Prednisolone—ankylosing spondylitis	0.000186	0.00283	CcSEcCtD
Phenobarbital—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000186	0.00282	CcSEcCtD
Phenobarbital—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000186	0.00282	CcSEcCtD
Phenobarbital—Arthralgia—Methotrexate—ankylosing spondylitis	0.000178	0.00271	CcSEcCtD
Phenobarbital—Myalgia—Methotrexate—ankylosing spondylitis	0.000178	0.00271	CcSEcCtD
Phenobarbital—Rash—Prednisolone—ankylosing spondylitis	0.000177	0.00269	CcSEcCtD
Phenobarbital—Dermatitis—Prednisolone—ankylosing spondylitis	0.000177	0.00269	CcSEcCtD
Phenobarbital—Headache—Prednisolone—ankylosing spondylitis	0.000176	0.00268	CcSEcCtD
Phenobarbital—Constipation—Prednisone—ankylosing spondylitis	0.000175	0.00266	CcSEcCtD
Phenobarbital—Confusional state—Methotrexate—ankylosing spondylitis	0.000172	0.00262	CcSEcCtD
Phenobarbital—Dizziness—Triamcinolone—ankylosing spondylitis	0.000171	0.0026	CcSEcCtD
Phenobarbital—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000171	0.00259	CcSEcCtD
Phenobarbital—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000168	0.00256	CcSEcCtD
Phenobarbital—Nausea—Prednisolone—ankylosing spondylitis	0.000167	0.00254	CcSEcCtD
Phenobarbital—Vomiting—Triamcinolone—ankylosing spondylitis	0.000164	0.0025	CcSEcCtD
Phenobarbital—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000164	0.00249	CcSEcCtD
Phenobarbital—Rash—Triamcinolone—ankylosing spondylitis	0.000163	0.00248	CcSEcCtD
Phenobarbital—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000163	0.00248	CcSEcCtD
Phenobarbital—Rash—Methylprednisolone—ankylosing spondylitis	0.000163	0.00247	CcSEcCtD
Phenobarbital—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000163	0.00247	CcSEcCtD
Phenobarbital—Urticaria—Prednisone—ankylosing spondylitis	0.000162	0.00247	CcSEcCtD
Phenobarbital—Headache—Triamcinolone—ankylosing spondylitis	0.000162	0.00246	CcSEcCtD
Phenobarbital—Headache—Methylprednisolone—ankylosing spondylitis	0.000162	0.00246	CcSEcCtD
Phenobarbital—Body temperature increased—Prednisone—ankylosing spondylitis	0.000162	0.00245	CcSEcCtD
Phenobarbital—Hypotension—Methotrexate—ankylosing spondylitis	0.00016	0.00243	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000156	0.00236	CcSEcCtD
Phenobarbital—Dizziness—Dexamethasone—ankylosing spondylitis	0.000155	0.00236	CcSEcCtD
Phenobarbital—Dizziness—Betamethasone—ankylosing spondylitis	0.000155	0.00236	CcSEcCtD
Phenobarbital—Nausea—Triamcinolone—ankylosing spondylitis	0.000154	0.00233	CcSEcCtD
Phenobarbital—Nausea—Methylprednisolone—ankylosing spondylitis	0.000153	0.00233	CcSEcCtD
Phenobarbital—Somnolence—Methotrexate—ankylosing spondylitis	0.000152	0.00231	CcSEcCtD
Phenobarbital—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000151	0.00229	CcSEcCtD
Phenobarbital—Vomiting—Dexamethasone—ankylosing spondylitis	0.000149	0.00227	CcSEcCtD
Phenobarbital—Vomiting—Betamethasone—ankylosing spondylitis	0.000149	0.00227	CcSEcCtD
Phenobarbital—Rash—Dexamethasone—ankylosing spondylitis	0.000148	0.00225	CcSEcCtD
Phenobarbital—Rash—Betamethasone—ankylosing spondylitis	0.000148	0.00225	CcSEcCtD
Phenobarbital—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000148	0.00225	CcSEcCtD
Phenobarbital—Dermatitis—Betamethasone—ankylosing spondylitis	0.000148	0.00225	CcSEcCtD
Phenobarbital—Headache—Betamethasone—ankylosing spondylitis	0.000147	0.00223	CcSEcCtD
Phenobarbital—Headache—Dexamethasone—ankylosing spondylitis	0.000147	0.00223	CcSEcCtD
Phenobarbital—Pain—Methotrexate—ankylosing spondylitis	0.000146	0.00222	CcSEcCtD
Phenobarbital—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000141	0.00214	CcSEcCtD
Phenobarbital—Nausea—Dexamethasone—ankylosing spondylitis	0.000139	0.00212	CcSEcCtD
Phenobarbital—Nausea—Betamethasone—ankylosing spondylitis	0.000139	0.00212	CcSEcCtD
Phenobarbital—Urticaria—Methotrexate—ankylosing spondylitis	0.000136	0.00206	CcSEcCtD
Phenobarbital—Dizziness—Prednisone—ankylosing spondylitis	0.000135	0.00205	CcSEcCtD
Phenobarbital—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000135	0.00205	CcSEcCtD
Phenobarbital—Vomiting—Prednisone—ankylosing spondylitis	0.00013	0.00197	CcSEcCtD
Phenobarbital—Rash—Prednisone—ankylosing spondylitis	0.000129	0.00196	CcSEcCtD
Phenobarbital—Dermatitis—Prednisone—ankylosing spondylitis	0.000129	0.00196	CcSEcCtD
Phenobarbital—Headache—Prednisone—ankylosing spondylitis	0.000128	0.00195	CcSEcCtD
Phenobarbital—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000126	0.00191	CcSEcCtD
Phenobarbital—Nausea—Prednisone—ankylosing spondylitis	0.000121	0.00184	CcSEcCtD
Phenobarbital—Dizziness—Methotrexate—ankylosing spondylitis	0.000113	0.00172	CcSEcCtD
Phenobarbital—Vomiting—Methotrexate—ankylosing spondylitis	0.000109	0.00165	CcSEcCtD
Phenobarbital—Rash—Methotrexate—ankylosing spondylitis	0.000108	0.00164	CcSEcCtD
Phenobarbital—Dermatitis—Methotrexate—ankylosing spondylitis	0.000108	0.00163	CcSEcCtD
Phenobarbital—Headache—Methotrexate—ankylosing spondylitis	0.000107	0.00163	CcSEcCtD
Phenobarbital—Nausea—Methotrexate—ankylosing spondylitis	0.000101	0.00154	CcSEcCtD
